5. Many drugs, such as Mectizan, are effective yet not very profitable. Such drugs are often referred to as "orphan drugs because, while worthy, no one is willing to step forward to be responsible for producing and marketing them. What responsibilities should pharmaceutical companies have for these orphan drugs?